Exploring the future of cell therapy research

LevitasBio Strengthens its C-Suite

Two Industry Veterans Join Already Strong Team MENLO Park – LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, announced the hiring of […]

LevitasBio Completes Series C Financing

MENLO PARK, CA – LevitasBio, Inc. (levitasbio.com), a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 […]

LevitasBio Unveils LeviPrep and LeviSelect Product Lines

LevitasBio Unveils LeviPrep and LeviSelect Product Lines New products expand end-to-end levitation-based workflowwith tissue dissociation and cell selection capabilities MENLO PARK, Calif, March 1, 2022 – LevitasBio Inc. today announced […]